阿奇霉素治疗58例成人支原体肺炎的临床效果观察  

Azithromycin Treatment of 58 Cases of Adult Mycoplasma Pneumoniae Clinical Effect Observed

作　　者：庞义新 

机构地区：[1]山东省泗水县人民医院,山东泗水273200

出　　处：《中国医药指南》2013年第13期406-407,共2页Guide of China Medicine

摘　　要：目的探讨阿奇霉素治疗成人支原体肺炎的临床效果。方法将116例成人支原体肺炎患者随机分为观察组和对照组各58例,观察组采用阿奇霉素进行治疗,对照组采用红霉素进行治疗,在既定疗程完成后观察两组患者的临床症状改变情况、临床症状改变时间以及不良反应情况并做对比分析。结果观察组有效率为98.3%,对照组有效率为89.7%,组间比较差异具统计学意义(P<0.05);观察组的咳嗽时间与肺部啰音消失时间均显著少于对照组(P<0.05);观察组不良反应发生率为12.1%,对照组为51.7%,组间比较有统计学意义(P<0.05)。结论阿奇霉素治疗支原体肺炎临床疗效满意,值得临床进一步推广应用。Objective Azithromycin treatment adult mycoplasma pneumonia clinical effect.Methods 116 cases of adult mycoplasma pneumonia were randomly divided into observation group and control group the fifty-eight patients,the observation group and control group in the azithromycin treatment using erythromycin treatment.Result The effective rate was 98.3% in the observation group and control group in effective rate was 89.7%,compared with difference between groups（P〈0.05）;The observation group in cough time and lung rale disappear time were significantly less than that in control group（P〈0.05）;Observation group of adverse reaction was 12.1%,and 51.7% in control group,group is compared between have statistical significance（P〈0.05）.Conclusion Azithromycin treatment mycoplasma pneumonia with clinical curative effect,it is worth clinical further popularization and application.

关 键 词：支原体肺炎 阿奇霉素 成人 

分 类 号：R563.1[医药卫生—呼吸系统]